1. Home
  2. CRVS vs UTL Comparison

CRVS vs UTL Comparison

Compare CRVS & UTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$14.03

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo UNITIL Corporation

UTL

UNITIL Corporation

HOLD

Current Price

$53.53

Market Cap

906.9M

Sector

Utilities

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRVS
UTL
Founded
2014
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Power Generation
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
906.9M
IPO Year
2016
1995

Fundamental Metrics

Financial Performance
Metric
CRVS
UTL
Price
$14.03
$53.53
Analyst Decision
Strong Buy
Buy
Analyst Count
6
2
Target Price
$30.17
$56.50
AVG Volume (30 Days)
1.0M
88.9K
Earning Date
05-07-2026
05-04-2026
Dividend Yield
N/A
3.65%
EPS Growth
48.04
1.37
EPS
N/A
2.11
Revenue
N/A
$536,000,000.00
Revenue This Year
N/A
$5.43
Revenue Next Year
N/A
$4.22
P/E Ratio
N/A
$28.89
Revenue Growth
N/A
8.33
52 Week Low
$4.05
$45.11
52 Week High
$26.95
$57.26

Technical Indicators

Market Signals
Indicator
CRVS
UTL
Relative Strength Index (RSI) 50.71 N/A
Support Level $12.74 N/A
Resistance Level $14.00 N/A
Average True Range (ATR) 0.69 0.00
MACD -0.12 0.00
Stochastic Oscillator 49.44 0.00

Price Performance

Historical Comparison
CRVS
UTL

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

About UTL UNITIL Corporation

Unitil Corp through its subsidiaries engages in the distribution of electricity and natural gas in its service territories in the states of New Hampshire, Massachusetts and Maine. Its natural gas operations include gas distribution utility operations and interstate gas transmission pipeline operations. It also engages in interstate natural gas transmission pipeline company, operating approximately 85 miles of underground gas transmission pipeline located in Maine and New Hampshire. The company's segments include Electric and Gas.

Share on Social Networks: